Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-25 @ 4:01 PM
NCT ID:
NCT02325557
Group ID:
EG003
Title:
Part B: ADXS31-142 + Pembrolizumab
Description:
Participants received ADXS31-142 1 × 10\^9 CFU IV Q3W (in a 12-week cycle) in combination with 200 mg pembrolizumab IV Q3W for three times, with a fourth pembrolizumab dose 3 weeks later (in 12 week-cycles) for up to 24 months or until disease progression or discontinuation.
Deaths Number Affected:
16
Deaths Number At Risk:
None
Serious Number Affected:
22
Serious Number At Risk:
37
Other Number Affected:
37
Other Number At Risk:
37
Study:
NCT02325557
Results Section:
NCT02325557
Adverse Events Module:
NCT02325557